Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2026-02-05 @ 8:44 PM
Study NCT ID:
NCT02073656
Status:
COMPLETED
Last Update Posted:
2018-11-16
First Post:
2014-02-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-02
Start Date Type:
None
Primary Completion Date:
2014-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-12
Completion Date Type:
ACTUAL
First Submit Date:
2014-02-25
First Submit QC Date:
None
Study First Post Date:
2014-02-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-08-30
Results First Submit QC Date:
None
Results First Post Date:
2016-10-21
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-19
Last Update Post Date:
2018-11-16
Last Update Post Date Type:
ACTUAL